A Rho-kinase inhibitor improves cardiac function after 24-hour heart preservation

Journal of Thoracic and Cardiovascular Surgery

Volumn 136, Issue 6, 2008, Pages 1586-1592

  Kobayashi, Mariko ^a   Tanoue, Yoshihisa ^a   Eto, Masataka ^a   Baba, Hironori ^a   Kimura, Satoshi ^a   Oda, Shinichiro ^a   Taniguchi, Kenichiro ^a   Tominaga, Ryuji ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; MYOSIN LIGHT CHAIN; RHO KINASE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOPLEGIA; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; ENDOTHELIAL DYSFUNCTION; GRAFT PRESERVATION; HEART FUNCTION; HEART MUSCLE REPERFUSION; HEART PERFORMANCE; HEART PRESERVATION; HEART RATE; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RABBIT; STARLING LAW;

1-(5-ISOQUINOLINESULFONYL)-2-METHYLPIPERAZINE; ANIMALS; CORONARY CIRCULATION; HEART TRANSPLANTATION; MALE; MODELS, ANIMAL; MODELS, CARDIOVASCULAR; ORGAN PRESERVATION; ORGAN PRESERVATION SOLUTIONS; PROTEIN KINASE INHIBITORS; RABBITS; RECOVERY OF FUNCTION; RHO-ASSOCIATED KINASES; TIME FACTORS; VENTRICULAR FUNCTION, LEFT;

EID: 57949093352     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2008.07.038     Document Type: Article

References (28)

1. Taylor D.O., Edwards L.B., Boucek M.M., Trulock E.P., Keck B.M., and Hertz M.I. The registry of the international society for heart lung transplantation: twenty-first official adult heart transplant report-2004. J Heart Lung Transplant 23 (2004) 796-803
2. Russo J.M., Chen J.M., Sorabella R.A., Martens T.P., Garrido M., Davis R.R., et al. The effect of ischemic time on survival after heart transplantation varies by donor age: an analysis of the united network for organ sharing database. J Thorac Cardiovasc Surg 133 (2007) 554-559
3. Simokawa H. Rho-kinase as a novel therapeutic target in treatment of cardiovascular disease. J Cardiovasc Pharmacol 39 (2002) 319-327
4. Shibuya M., Suzuki Y., Suguta K., Saito I., Sasaki T., Takakura K., et al. Effect of AT877 on cerebral vasospasm after aneurismal subarachnoid hemorrhage: results of a protective placebo-controlled double-blind trial. J Neurosurg 76 (1992) 571-577
5. Shimokawa H., Hiramori K., Iinuma H., Hosoda S., Kishida H., Osada H., et al. Anti-anginal effect of fasudil, a Rho-kinase inhibitor, in patients with stable angina: a multicenter study. J Cardiovasc Pharmacol 40 (2002) 751-761
6. Narumiya S. The small GTPase Rho: cellular signal function of signal transduction. J Biochem (Tokyo) 120 (1996) 215-228
7. Amano M., Chihara K., Kimura K., Fukata Y., Nakamura N., Matsumura Y., et al. Formation of actin stress fibers and focal adhesions enhanced by Rho-kinase. Science 275 (1997) 1308-1311
8. Horwitz A.R., and Parsons J.T. Cell migration: movin' on. Science 286 (1999) 1102-1103
9. Hattori T., Shimokawa H., Higashi M., Hiroki J., Mukai Y., Tsutsui H., et al. Long-term inhibition of Rho-kinase suppresses left ventricular remodeling after myocardial infarction in mice. Circulation 109 (2004) 2234-2239
10. Yada T., Shimokawa H., Hiramatsu O., Kajita T., Shigeto F., Tanaka E., et al. Beneficial effect of hydroxyfasudil, a specific Rho-kinase inhibitor, on ischemia/reperfusion injury in canine coronary microcirculation in vivo. J Am Coll Cardiol 45 (2005) 599-607
11. Kajihara N., Morita S., Tanoue Y., Boku N., Eto M., Nishida T., et al. The UW solution has greater potential for longer preservation periods than the Cersior solution: comparative study for ventricular and coronary endothelial function after 24-h heart preservation. Eur J Cardiothorac Surg 29 (2006) 784-789
12. Kajihara T., Morita S., Nishida T., Tatewaki H., Eto M., Egashira K., et al. Transfection with a dominant-negative inhibitor of myocyte chemoattractant protein-1 gene improves cardiac function after 6 hours of cold preservation. Circulation 108 suppl II (2003) II213-II218
13. Boku N., Tanoue N., Kajihara N., Eto M., Masuda M., and Morita S. A comparative study of cardiac preservation with Cersior or university of Wisconsin solution with or without prior administration of cardioplegia. J Heart Lung Transplant 25 (2006) 219-225
14. Tanoue Y., Morita S., Hisahara M., Tominaga R., Kawachi Y., and Yasui H. Arresting donor hearts with extracellular-type cardioplegia prevents vasoconstriction induced by UW solution. Cardiovasc Surg 6 (1998) 622-628
15. Hallam K.M., Edirisinghe I., Balasuriya U.B.R., Gunawardena S., Bravo E.M., Ravi K., et al. Effects of mitral regurgitation on the reflex diuresis to pulmonary lymphatic obstruction in rabbits. Exp Lung Res 33 (2007) 259-275
16. Furuyama T., Komori K., Shimokawa H., Matsumoto Y., Uwatoku T., Hirano K., et al. Long-term inhibition of Rho kinase suppresses internal thickening in autologous vein grafts in rabbits. J Cardiovasc Surg 43 (2006) 1249-1255
17. Shiotani S., Shimoda M., Suehiro T., Soejima Y., Yosizumi T., Shimokawa H., et al. Involvement of Rho-kinase in cold ischemia-reperfusion injury after liver transplantation in rats. Transplantation 78 (2004) 375-382
18. Inokuchi K., Ito A., Fukumoto Y., Matoba T., Shiose A., Nisida T., et al. Usefulness of fasudil, a Rho-kinase inhibitor, to treat intractable severe coronary spasm after coronary artery bypass surgery. J Cardiovasc Pharmacol 44 (2004) 275-277
19. Zhao Z., Velez D.A., Wang N., Hewan-Lowe K.O., Nakamura M., Guyton R.A., et al. Progressively developed myocardial apoptotic cell death during late phase of reperfusion. Apoptosis 6 (2001) 279-290
20. Lefer A.M., Tsao P.S., Lefer D.J., and Ma X.L. Role of endothelial dysfunction in the pathogenesis of reperfusion injury after myocardial ischemia. FASEB J 261 (1991) 2029-2034
21. Kubes P., Suzuki M., and Granger D.N. Nitric oxide: an endogenous modular of leukocyte adhesion. Proc Natl Acad Sci U S A 88 (1991) 4651-4655
22. Gryglewski R.J., Palmer R.M.J., and Moncada S. Superoxide anion is involved in the breakdown of endothelium-derived relaxing factor. Nature 320 (1986) 454-456
23. Jones S.P., Girod W.G., Palazzo A.J., Granger D.N., Grisham M.B., Jourd'Heuil D., et al. Myocardial ischemia-reperfusion injury is exacerbated in the absence of endothelial cell nitric oxide synthase. Am J Physiol Heart Circ Physiol 276 (1999) H1567-H1573
24. Bao W., Hu E., Boyce R., Mirabile R., Thudium T.D., Ma X., et al. Inhibition of Rho-kinase protects the heart against ischemia/reperfusion injury. Cardiovasc Res 61 (2004) 548-558
25. Laufs U., and Liao J.K. Post-transcriptional regulation of endothelial nitric oxide synthase mRNA stability by Rho GTPase. J Biol Chem 273 (1998) 24266-24271
26. Asano T., Ikegaki I., Satoh S., Suzuki Y., Shibuya M., Takayasu M., et al. Mechanism of action of a novel antivasospasm drug, HA1077. J Pharmacol Exp Ther 241 (1987) 1033-1040
27. Asano T., Suzuki T., Tsuchiya M., Satoh S., Ikegaki I., Shibuya M., et al. Vasodilator actions of HA1077 in vitro and in vivo putatively mediated by the inhibition of protein kinase. Br J Pharmacol 98 (1989) 1091-1100
28. Hollenberg S.M., Klein L.W., Parrillo J.E., Scherer M., Burns D., Tamburro P., et al. Coronary endothelial dysfunction after heart transplantation predicts allograft vasculopathy and cardiac death. Circulation 104 (2001) 3091-3094